Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats
Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats
复制标题
DOI:
10.1161/01.str.0000083622.65684.21
复制
发表时间:
2003-09-01
期刊:
影响因子:
8.3
通讯作者:
Schmid-Elsaesser, R
中科院分区:
文献类型:
--
作者:
Zausinger, S;Schöller, K;Schmid-Elsaesser, R
Background and Purpose-We have recently demonstrated that pretreatment with magnesium (calcium and glutamate antagonist) and tirilazad ( antioxidant) in combination with intraischemic mild hypothermia (33degreesC) (MTH) offers superior neuroprotective efficacy in a rat model of focal transient cerebral ischemia. In the present study, we investigated the time window of this treatment strategy with a posttreatment regimen to define its role for stroke patients.Methods-We subjected 48 Sprague-Dawley rats to 90 minutes of middle cerebral artery occlusion by an intraluminal filament. Bilateral regional cerebral blood flow was continuously recorded by laser Doppler flowmetry. Combination therapy with MTH was started at 0, 1, 3, and 5 hours after induction of ischemia. Drugs were given in 1-hour intervals, and hypothermia was maintained for 2 hours. Neurological deficits were assessed daily. Infarct size was planimetrically determined on postoperative day 7.Results-Combination therapy with MTH significantly reduced infarct volume compared with normothermic controls by -74%, -49%, and -45% when applied at 0, 1, and 3 hours after induction of ischemia. Furthermore, these treatment groups showed less neurological deficits on postischemic days 1 and 2 (P